Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cronos Group Inc. - Common Share (NQ: CRON )

1.885 +0.035 (+1.89%)
Streaming Delayed Price Updated: 9:31 AM EST, Feb 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 236,645
Open 1.890
Bid (Size) 1.880 (15)
Ask (Size) 1.890 (7)
Prev. Close 1.850
Today's Range 1.875 - 1.900
52wk Range 1.830 - 3.140
Shares Outstanding 371,805,547
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cronos Group Reports 2024 Fourth Quarter and Full-Year Results
From Cronos Group Inc.
Via GlobeNewswire
Earnings Scheduled For February 27, 2025
Via Benzinga

Performance

YTD
-8.50%
-8.50%
1 Month
-0.26%
-0.26%
3 Month
-9.38%
-9.38%
6 Month
-12.33%
-12.33%
1 Year
-18.04%
-18.04%

More News

Read More
Cronos Group Inc. to Hold 2024 Fourth Quarter and Full-Year Earnings Conference Call on February 27, 2025
From Cronos Group Inc.
Via GlobeNewswire
Illinois Recorded $2bn in Cannabis Sales in 2024
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Illinois Recorded $2bn in Cannabis Sales in 2024
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Top Picks 2025: Altria Group
Via Talk Markets
Topics Stocks / Equities
Earnings Scheduled For November 12, 2024
Via Benzinga
420 with CNW — Colorado Springs Residents Sue City Over Vote to Repeal Recreational Marijuana
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Why Aurora Cannabis Stock Is Skyrocketing Wednesday: What About Canopy, Tilray, Cronos?
Via Benzinga
Topics Cannabis
Exposures Cannabis
420 with CNW — Arkansas Governor Says Medical Cannabis Taxes Will Help Feed Children
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Governor Wants Wisconsin Voters to Legalize Marijuana as GOP Lawmakers Block Reform Efforts
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Bullish Wednesday For Marijuana Stocks - Cara Therapeutics, MPX International Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Foreign Companies Could Tap into Germany’s Marijuana Pilot Programs
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Elton John Thinks Marijuana Legalization in Canada, the US is a Grave Mistake
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand
Via Benzinga
Topics Cannabis
Exposures Cannabis
What Marijuana Reclassification Could Mean for Washington D.C.
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Nebraska AG Pledges That Ongoing Investigations Won’t Impact Cannabis Measure’s Certification
Via CannabisNewsWire
Topics Cannabis Lawsuit
Exposures Cannabis Financial Legal
420 with CNW — Study Finds That Not Everyone Can Improve Their Sleep by Using Marijuana
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Cronos CEO Mike Gorenstein Says He's Optimistic About Trump's Impact On Cannabis
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Cronos Group Q3 Financials; Total Net Revenue Was Up; International Sales Were Up 29%
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Why Cronos Group Stock Popped 9% Today
Via The Motley Fool
Cronos Group (CRON) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Cronos Cannabis Co. Reports 38% YOY Increase In Q3 Revenue, Boosts International Sales
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cronos Group Reports 2024 Third Quarter Results
From Cronos Group Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.